Le Lézard
Classified in: Health, Science and technology
Subject: AWD

Leidos Achieves Top 10 Ranking on 2018 Healthcare Informatics Top 100 List


RESTON, Va., July 9, 2018 /PRNewswire/ -- Leidos (NYSE: LDOS), a FORTUNE® 500 science and technology leader, has been ranked ninth on the annual Healthcare Informatics 100 list. The feature is a compilation of the top 100 companies with the highest revenues derived from healthcare IT products and services earned in the U.S. based on revenue information from the previous year. This is the second consecutive year Leidos has made the list.

Leidos logo. (PRNewsFoto/Leidos)

Healthcare Informatics partnered with Porter Research and ST Advisors to verify the revenue of each company. The list includes income derived from the sale of computer hardware, software and related services to healthcare providers -- including hospitals, ambulatory clinics, and physician practices -- as well as in the payer, health information management, employer, and vendor-to-vendor market.

Leidos, which also ranked ninth on the 2017 list, provides services and solutions to commercial and government clients in information technology, biomedical research, and public health. From conducting groundbreaking research to fight diseases such as cancer and AIDS, to implementing and optimizing electronic health records, Leidos provides solutions focused on improving patient care and reducing cost. The company provides a broad range of capabilities for hospitals and health systems and also develops and supports large-scale technology programs for every U.S. federal agency focused on health, including the Department of Defense, Veterans Affairs, and the Department of Health and Human Services.

"Being included in the Top 100 for a consecutive year underscores our dedication to providing healthcare solutions that improve the quality of life for people around the world," said Jon Scholl, Leidos Health Group President. "Our growing scale allows us to better compete for challenging assignments and opportunities to create efficiencies within large healthcare systems. Leidos' clinical, operational, and technology experts use their deep knowledge to help our customers modernize their health IT systems, cut costs, and deliver better value for patients."

About Leidos 
Leidos is a Fortune 500® information technology, engineering, and science solutions and services leader working to solve the world's toughest challenges in the defense, intelligence, homeland security, civil, and health markets. The company's 31,000 employees support vital missions for government and commercial customers. Headquartered in Reston, Virginia, Leidos reported annual revenues of approximately $10.17 billion for the fiscal year ended December 29, 2017. For more information, visit www.Leidos.com.  

Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company's Annual Report on Form 10-K for the period ended December 29, 2017, and other such filings that Leidos makes with the SEC from time to time. Due to such uncertainties and risks, readers are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date hereof.

 

Contact:    


Melissa Koskovich   

Jason Kello  

(571) 526-6850   

(571) 526-6011

[email protected]   

[email protected]    

 

 

SOURCE Leidos


These press releases may also interest you

at 23:33
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

at 22:54
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

at 22:03
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:42
The Honourable Ya'ara Saks, Minister of Mental Health and Addictions and Associate Minister of Health, will host an event at the University of Manitoba to highlight the federal budget's investments to boost funding for research in Canada. A media...



News published on and distributed by: